Heart failure drug classes and 30-day unplanned hospital readmission among patients with heart failure in Ethiopia.
Drug therapy
Ethiopia
Heart failure
Hospital readmission
Journal
Journal of pharmaceutical health care and sciences
ISSN: 2055-0294
Titre abrégé: J Pharm Health Care Sci
Pays: England
ID NLM: 101672177
Informations de publication
Date de publication:
27 Nov 2023
27 Nov 2023
Historique:
received:
16
06
2023
accepted:
20
11
2023
medline:
28
11
2023
pubmed:
28
11
2023
entrez:
28
11
2023
Statut:
epublish
Résumé
Drug therapy is a crucial aspect of heart failure management and has been shown to reduce morbidity and mortality in heart failure patients. However, the comparative effects of these drug classes on readmission rates have not been well studied. Therefore, the aim of this study was to examine the association between different classes of heart failure drugs and 30-day readmission rates in patients with heart failure. A multicenter, hospital-based retrospective cohort design was employed and 572 randomly selected patients with heart failure were included. Data were entered in Epi-data version 4.6 and analyzed with STATA version 17. Kaplan-Meier and log-rank tests were used to estimate and compare survival time. A Cox proportional hazard model was utilized, employing both bi-variable and multi-variable analyses, to examine the effect of predictors on the timing of unplanned hospital readmissions. The strength of the association was assessed using an adjusted hazard ratio (aHR), and statistical significance was declared for p-values < 0.05 and a 95% confidence interval (CI). In this study, a total of 151 (26.40%) heart failure patients were readmitted within 30 days of discharge. In the multivariate cox proportional hazards analysis being an age (> 65 year) (AHR: 2.34, 95%CI: 1.63, 3.37), rural in residency (AHR: 1.85, 95%CI: 1.07, 3.20), hospital stays > 7 Days (AHR: 3.68, 95%CI: 2.51,5.39), discharge with Diuretics (AHR: 2.37, 95%CI: 1.45, 3.86), and discharge with Beta-Blocker (AHR: 0.48, 95%CI: 0 0.34, 0.69) were identified as independent predictors of unplanned hospital readmission. Elderly patients, being in rural areas, longer hospital stays, and discharges of patients on diuretics and not on beta-blockers were independent predictors of unplanned hospital readmission. Therefore, working on these factors will help to reduce the hazard of unplanned hospital readmissions, improve patient outcomes, and increase the efficiency of heart failure management.
Sections du résumé
BACKGROUND
BACKGROUND
Drug therapy is a crucial aspect of heart failure management and has been shown to reduce morbidity and mortality in heart failure patients. However, the comparative effects of these drug classes on readmission rates have not been well studied. Therefore, the aim of this study was to examine the association between different classes of heart failure drugs and 30-day readmission rates in patients with heart failure.
METHOD
METHODS
A multicenter, hospital-based retrospective cohort design was employed and 572 randomly selected patients with heart failure were included. Data were entered in Epi-data version 4.6 and analyzed with STATA version 17. Kaplan-Meier and log-rank tests were used to estimate and compare survival time. A Cox proportional hazard model was utilized, employing both bi-variable and multi-variable analyses, to examine the effect of predictors on the timing of unplanned hospital readmissions. The strength of the association was assessed using an adjusted hazard ratio (aHR), and statistical significance was declared for p-values < 0.05 and a 95% confidence interval (CI).
RESULTS
RESULTS
In this study, a total of 151 (26.40%) heart failure patients were readmitted within 30 days of discharge. In the multivariate cox proportional hazards analysis being an age (> 65 year) (AHR: 2.34, 95%CI: 1.63, 3.37), rural in residency (AHR: 1.85, 95%CI: 1.07, 3.20), hospital stays > 7 Days (AHR: 3.68, 95%CI: 2.51,5.39), discharge with Diuretics (AHR: 2.37, 95%CI: 1.45, 3.86), and discharge with Beta-Blocker (AHR: 0.48, 95%CI: 0 0.34, 0.69) were identified as independent predictors of unplanned hospital readmission.
CONCLUSION
CONCLUSIONS
Elderly patients, being in rural areas, longer hospital stays, and discharges of patients on diuretics and not on beta-blockers were independent predictors of unplanned hospital readmission. Therefore, working on these factors will help to reduce the hazard of unplanned hospital readmissions, improve patient outcomes, and increase the efficiency of heart failure management.
Identifiants
pubmed: 38012803
doi: 10.1186/s40780-023-00320-y
pii: 10.1186/s40780-023-00320-y
pmc: PMC10680257
doi:
Types de publication
Journal Article
Langues
eng
Pagination
49Informations de copyright
© 2023. The Author(s).
Références
JACC CardioOncol. 2020 Sep;2(3):414-424
pubmed: 33073249
Health Policy Plan. 2021 Feb 16;35(10):1318-1327
pubmed: 33169151
J Am Coll Cardiol. 2020 Nov 17;76(20):2418-2420
pubmed: 33183518
Nat Rev Cardiol. 2016 Jun;13(6):368-78
pubmed: 26935038
BMC Res Notes. 2020 Feb 21;13(1):89
pubmed: 32085803
Int J Gen Med. 2018 Apr 09;11:127-141
pubmed: 29670391
Pharmacol Res. 2020 Jan;151:104587
pubmed: 31809852
Adv Ther. 2018 Mar;35(3):311-323
pubmed: 29488151
Heart Surg Forum. 2020 Jul 07;23(4):E470-E474
pubmed: 32726210
Curr Cardiol Rev. 2013 May;9(2):157-73
pubmed: 23597299
Diabetes Obes Metab. 2020 Aug;22(8):1243-1262
pubmed: 32243706
Heart Fail Rev. 2019 Mar;24(2):177-187
pubmed: 30488242
Nat Rev Dis Primers. 2020 Mar 5;6(1):16
pubmed: 32139695
Eur J Heart Fail. 2020 Apr;22(4):683-691
pubmed: 31797505
Int Heart J. 2015;56(2):219-25
pubmed: 25740584
Am J Cardiol. 2015 Aug 1;116(3):400-5
pubmed: 26037295
Circ Heart Fail. 2018 Apr;11(4):e004310
pubmed: 29618581
J Am Heart Assoc. 2018 Sep 18;7(18):e009863
pubmed: 30371187
Circulation. 2016 Mar 8;133(10):967-78
pubmed: 26846769
BMJ Open. 2018 May 10;8(5):e021798
pubmed: 29748348
Medicines (Basel). 2020 May 20;7(5):
pubmed: 32443705
Eur J Heart Fail. 2019 Feb;21(2):137-155
pubmed: 30600580
J Am Heart Assoc. 2022 Apr 5;11(7):e023935
pubmed: 35229656
Adv Ther. 2019 Feb;36(2):278-297
pubmed: 30591990
Int J Heart Fail. 2020 Apr 21;2(2):131-144
pubmed: 36263288
JACC Heart Fail. 2017 Aug;5(8):578-588
pubmed: 28501521
Intern Med J. 2023 Feb;53(2):262-270
pubmed: 34633136
Heart Lung Circ. 2019 Feb;28(2):277-283
pubmed: 29191505
PLoS One. 2020 Dec 22;15(12):e0244231
pubmed: 33351823
Eur J Heart Fail. 2016 Sep;18(9):1132-40
pubmed: 27108481
Acta Cardiol Sin. 2017 May;33(3):292-300
pubmed: 28559660
J Clin Pharm Ther. 2017 Feb;42(1):51-57
pubmed: 27791272